Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial.
de Pádua Souza C, Carneiro ASB, de Oliveira Lessa AC, Lacerda DC, Paiva CE, Zorzetto MMC, de Freitas AJA, Santana IVV, de Oliveira MA, Palmero EI, Marques MMC, Reinert T.
de Pádua Souza C, et al. Among authors: paiva ce.
Breast Cancer Res Treat. 2023 Nov;202(1):57-65. doi: 10.1007/s10549-023-07011-0. Epub 2023 Aug 14.
Breast Cancer Res Treat. 2023.
PMID: 37578666
Free PMC article.
Clinical Trial.